IVD MEDICAL (01931) repurchased 1,310,000 shares at a cost of HK$8.01 million on November 18th.
Huajian Medical (01931) issued an announcement on November 18, 2025, stating that the company invested 8.0016 million...
IVD MEDICAL (01931) announces that on November 18, 2025, the company has allocated 8.01 million Hong Kong dollars to repurchase 1.31 million shares, at a repurchase price of 5.74-6.25 Hong Kong dollars per share.
Related Articles
US Stock Market Move | Merck & Co., Inc. (MRK.US) rose more than 4% as Winrevair succeeded in a new mid-stage trial for lung indications.
US Stock Market Move | iQIYI, Inc. Sponsored ADR Class A (IQ.US) rose more than 4%, with overseas business continuing to maintain high-speed growth.
US Stock Market Move | Canaan Inc. Sponsored ADR Class A (CAN.US) rose 9.8% in Q3, with mining business revenue increasing by 241% year-on-year.
US Stock Market Move | Merck & Co., Inc. (MRK.US) rose more than 4% as Winrevair succeeded in a new mid-stage trial for lung indications.
US Stock Market Move | iQIYI, Inc. Sponsored ADR Class A (IQ.US) rose more than 4%, with overseas business continuing to maintain high-speed growth.
US Stock Market Move | Canaan Inc. Sponsored ADR Class A (CAN.US) rose 9.8% in Q3, with mining business revenue increasing by 241% year-on-year.
RECOMMEND
Tech Stocks, Crypto, and Gold Slump; U.S. Equities Break Key Support Amid Broad-based Sell-off
18/11/2025
Goldman Sachs’ Ten-year Investment Outlook: Artificial Intelligence and Emerging Markets As Core Growth Engines
18/11/2025
Consensus On Multiple Outcomes, Easing Trade Tensions, China–Germany High-level Financial Dialogue Convened In Beijing
18/11/2025
